Literature DB >> 21779220

Breast Cancer Screening Program in Stockholm County, Sweden - Aspects of Organization and Quality Assurance.

Helena Lind1, Gunilla Svane, Levent Kemetli, Sven Törnberg.   

Abstract

The population-based breast cancer screening program in Stockholm County was initiated in 1989. The program follows the recommendations issued by the Swedish Board of Health and Welfare, and is in agreement with guidelines from the European Commission. Individual data is available for all women in Stockholm County aged 40-69 years since initiation of the program in 1989. The participation rate exceeds 70%, the recall rate averages 3%, and the detection rate is 0.5%. The introduction of the breast cancer screening program in Stockholm County has reduced breast cancer mortality by 29% and among participants by 52%. The breast screening program is well organized and functioning, and well adapted to its purpose. Follow-up ensures a good quality process with the aim of reducing breast cancer mortality.

Entities:  

Year:  2010        PMID: 21779220      PMCID: PMC3132962          DOI: 10.1159/000321255

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  7 in total

1.  Reduction in breast cancer mortality from organized service screening with mammography: 1. Further confirmation with extended data.

Authors: 
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-01       Impact factor: 4.254

2.  Pattern of participation in a cohort aged 50-60 years at first invitation to the service-screening programme with mammography in Stockholm county, Sweden.

Authors:  Sven Törnberg; Levent Kemetli; Gunilla Svane; Måns Rosén; Magnus Stenbeck; Lennarth Nyström
Journal:  Prev Med       Date:  2005 Sep-Oct       Impact factor: 4.018

3.  Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening.

Authors:  Laszlo Tabar; Ming-Fang Yen; Bedrich Vitak; Hsiu-Hsi Tony Chen; Robert A Smith; Stephen W Duffy
Journal:  Lancet       Date:  2003-04-26       Impact factor: 79.321

4.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial.

Authors:  I Andersson; K Aspegren; L Janzon; T Landberg; K Lindholm; F Linell; O Ljungberg; J Ranstam; B Sigfússon
Journal:  BMJ       Date:  1988-10-15

5.  The general mammography screening program in Stockholm. Organisation and first-round results.

Authors:  E K Lidbrink; S A Törnberg; E M Azavedo; J O Frisell; M L Hjalmar; K S Leifland; T B Sahlstedt; L Skoog
Journal:  Acta Oncol       Date:  1994       Impact factor: 4.089

6.  Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare.

Authors:  L Tabár; C J Fagerberg; A Gad; L Baldetorp; L H Holmberg; O Gröntoft; U Ljungquist; B Lundström; J C Månson; G Eklund
Journal:  Lancet       Date:  1985-04-13       Impact factor: 79.321

7.  Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial.

Authors:  Sue M Moss; Howard Cuckle; Andy Evans; Louise Johns; Michael Waller; Lynda Bobrow
Journal:  Lancet       Date:  2006-12-09       Impact factor: 79.321

  7 in total
  7 in total

1.  Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.

Authors:  Fredrik Strand; Keith Humphreys; Abbas Cheddad; Sven Törnberg; Edward Azavedo; John Shepherd; Per Hall; Kamila Czene
Journal:  Breast Cancer Res       Date:  2016-10-05       Impact factor: 6.466

2.  Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.

Authors:  Fredrik Strand; Keith Humphreys; Johanna Holm; Mikael Eriksson; Sven Törnberg; Per Hall; Edward Azavedo; Kamila Czene
Journal:  Breast Cancer Res       Date:  2018-04-18       Impact factor: 6.466

3.  Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.

Authors:  Wendy Yi-Ying Wu; Sven Törnberg; Klara Miriam Elfström; Xijia Liu; Lennarth Nyström; Håkan Jonsson
Journal:  Breast Cancer Res       Date:  2018-12-17       Impact factor: 6.466

4.  Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis.

Authors:  Matejka Rebolj; Valentina Assi; Adam Brentnall; Dharmishta Parmar; Stephen W Duffy
Journal:  Br J Cancer       Date:  2018-05-08       Impact factor: 7.640

5.  No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.

Authors:  Gabriella Frisk; Sara Ekberg; Elisabet Lidbrink; Sandra Eloranta; Malin Sund; Irma Fredriksson; Mats Lambe; Karin E Smedby
Journal:  Breast Cancer Res       Date:  2018-11-20       Impact factor: 6.466

6.  Discontinuation of adjuvant hormone therapy among breast cancer patients not previously attending mammography screening.

Authors:  Wei He; Louise Eriksson; Sven Törnberg; Fredrik Strand; Per Hall; Kamila Czene
Journal:  BMC Med       Date:  2019-01-31       Impact factor: 8.775

7.  Mammography features for early markers of aggressive breast cancer subtypes and tumor characteristics: A population-based cohort study.

Authors:  Pui San Tan; Maya Alsheh Ali; Mikael Eriksson; Per Hall; Keith Humphreys; Kamila Czene
Journal:  Int J Cancer       Date:  2020-10-06       Impact factor: 7.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.